Vapotherm

Vapotherm, Inc. is a publicly traded company headquartered in Exeter, New Hampshire. The company employs 327 people and generated $102.6 million in revenue. Vapotherm specializes in respiratory therapy solutions. Their flagship product, the Precision Flow® system, utilizes high velocity therapy to provide patients with Mask-Free respiratory support. This therapy is designed to deliver heated, humidified high flow oxygen, offering a comfortable alternative to traditional respiratory care methods. The company targets healthcare providers, particularly in emergency departments and intensive care units, who treat patients experiencing respiratory distress. The Precision Flow® system stands out for its ability to provide both oxygenation and Mask-Free respiratory support. This innovative approach offers patients a more comfortable experience while providing clinicians with a reliable tool for managing a range of respiratory conditions. As the inventor of high flow nasal cannula and its advanced form, Vapotherm holds a leading position in the field of respiratory therapy. For more information about Vapotherm and its solutions, visit their website at vapotherm.com. The company's common stock trades on the OTCQX tier of the OTC Markets under the symbol “VAPO”.